A wish-list of centrist proposals for the lame-duck Congress
Good things come in threes. But we’re greedy and have five
When members of Congress return to Washington next week, Thanksgiving will be over and the annual festival of asking for stuff will begin. The Economist has its own wish-list for members of the House and Senate in the lame-duck session, when legislators can be more open to doing business. Since the biggest obstacle to these wishes being granted is the Senate filibuster, which means finding ten Republican votes, this list is particularly aimed at the five Republican senators who are retiring, plus those who voted for the chips Act and infrastructure law, both of which passed with Republican support. In journalism, branches of government and adorations of the Magi, three is the magic number. But we are greedy, so here are five.
This article appeared in the Leaders section of the print edition under the headline “All we want”
Leaders November 26th 2022
- Europe faces an enduring crisis of energy and geopolitics
- Disney brings back a star of the past. But its real problem is the script
- A wish-list of centrist proposals for the lame-duck Congress
- Russian “offshore journalists” need help, not hindrance
- COP27 was disappointing, but US-China climate diplomacy is thawing
More from Leaders
Sir Keir Starmer should aim higher in his reset with the EU
And he needs to be clearer about what Britain wants
To make electricity cheaper and greener, connect the world’s grids
Less than 3% of the world’s power is internationally traded—a huge wasted opportunity
Chinese AI is catching up, posing a dilemma for Donald Trump
The success of cheap Chinese models threatens America’s technological lead
America has an imperial presidency
And in Donald Trump, an imperialist president for the first time in over a century
Tariffs will harm America, not induce a manufacturing rebirth
Donald Trump’s pursuit of tariffs will make the world poorer—and America, too
How to improve clinical trials
Involving more participants can lead to new medical insights